← All drugs
Drug

Propylthiouracil

66 flagged reaction(s) · 1,501 total co-reports · max PRR 98.5
Important: Reactions below are the flagged terms from this drug’s FAERS report history (min. 3 co-reports per term) — PRR/ROR indicate disproportionality in spontaneous reporting, not causation. Data from FDA FAERS via openFDA. Last recalculated: 2026-09-14.
Reaction Co-reports (a) PRR ROR Signal
1 Hyperthyroidism 138 98.5 105.5 signal
2 Cardiogenic Shock 50 36.0 36.8 signal
3 Acute Hepatic Failure 46 34.7 35.5 signal
4 Agranulocytosis 60 33.3 34.3 signal
5 Vasculitis 32 28.1 28.6 signal
6 Sinus Bradycardia 16 16.9 17.0 signal
7 Premature Baby 49 16.6 17.0 signal
8 Hepatic Encephalopathy 15 16.5 16.6 signal
9 Hepatotoxicity 35 16.2 16.4 signal
10 Premature Delivery 25 16.0 16.2 signal
11 Hypothyroidism 47 15.1 15.4 signal
12 Foetal Exposure During Pregnancy 117 14.8 15.6 signal
13 Circulatory Collapse 24 14.4 14.5 signal
14 Exposure During Pregnancy 85 14.0 14.6 signal
15 Drug-induced Liver Injury 38 12.6 12.8 signal
16 Caesarean Section 14 12.2 12.3 signal
17 Multiple Organ Dysfunction Syndrome 33 12.1 12.3 signal
18 Hyperbilirubinaemia 11 10.9 11.0 signal
19 Renal Tubular Necrosis 10 10.4 10.5 signal
20 Drug Reaction With Eosinophilia And Systemic Symptoms 25 10.0 10.1 signal
21 Cardiomegaly 12 9.9 10.0 signal
22 Maternal Exposure During Pregnancy 76 8.8 9.1 signal
23 Hepatitis 22 8.8 8.9 signal
24 Cholestasis 16 8.6 8.6 signal
25 Mitral Valve Incompetence 9 8.1 8.2 signal
26 Ventricular Tachycardia 13 8.0 8.1 signal
27 Hepatic Failure 23 7.8 7.9 signal
28 Blood Thyroid Stimulating Hormone Increased 7 7.8 7.8 signal
29 Eosinophilia 13 7.6 7.7 signal
30 Drug Exposure During Pregnancy 25 7.4 7.5 signal
31 Rhabdomyolysis 30 7.4 7.5 signal
32 Disseminated Intravascular Coagulation 10 7.2 7.3 signal
33 Sinus Tachycardia 10 7.2 7.3 signal
34 Cardiac Arrest 55 6.8 7.0 signal
35 Liver Injury 16 6.8 6.8 signal
36 Drug Toxicity 9 6.7 6.7 signal
37 Thyroid Disorder 10 6.6 6.7 signal
38 Brain Oedema 8 6.5 6.5 signal
39 Jaundice 17 6.4 6.5 signal
40 Product Physical Issue 12 6.2 6.2 signal
41 Adrenal Insufficiency 7 6.0 6.0 signal
42 International Normalised Ratio Increased 16 5.7 5.7 signal
43 Nephropathy 5 5.5 5.5 signal
44 Cardio-respiratory Arrest 22 5.3 5.4 signal
45 Treatment Noncompliance 27 5.1 5.1 signal
46 Toxic Skin Eruption 5 5.1 5.1 signal
47 Temperature Intolerance 5 5.0 5.0 signal
48 Red Blood Cell Sedimentation Rate Increased 5 4.6 4.6 signal
49 Drug Ineffective For Unapproved Indication 24 4.4 4.4 signal
50 Abortion Spontaneous 17 4.3 4.4 signal
51 Anorexia 5 3.9 3.9 signal
52 Cardiac Failure Congestive 30 3.8 3.8 signal
53 Cerebral Haemorrhage 13 3.7 3.7 signal
54 Myocarditis 4 3.6 3.6 signal
55 Rebound Effect 4 3.6 3.6 signal
56 Drug Resistance 9 3.6 3.6 signal
57 Hepatic Cytolysis 4 3.3 3.4 signal
58 No Therapeutic Response 4 3.3 3.3 signal
59 Abortion Induced 3 3.3 3.3 no signal
60 Hepatocellular Injury 4 2.9 2.9 no signal
61 Pregnancy 5 2.5 2.5 no signal
62 Product Taste Abnormal 3 2.3 2.3 no signal
63 Drug Dispensing Error 3 2.0 2.0 no signal
64 Application Site Pruritus 3 1.4 1.4 no signal
65 Intentional Overdose 8 1.3 1.3 no signal
66 Pharmaceutical Product Complaint 3 1.2 1.2 no signal